 | | Tipranavir (Aptivus) |  | | Published
July 13, 2005; Updated
October 19, 2011 | Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-03-09 | | | Selected References | | 4. | Boehringer Ingelheim Pharmaceuticals, Inc. Tipranavir Anti-Viral Drugs Advisory Committee (AVDAC) Briefing Document. April 19, 2005. Available at: www.fda.gov/ohrms/dockets/ac/05/briefing/2005-4139b1-02-boehringer.pdf. | |
| 5. | Tipranavir Review Team (HFD-530), Memorandum to FDA Antiviral Advisory Committee Members/Guests. April 22, 2005. Available at: www.fda.gov/ohrms/dockets/ac/05/briefing/2005-4139b1-01-fda.pdf | |
| 6. | Aptivus [package insert]. Boehringer Ingelheim GmbH, Germany; 2006. Available at: www.fda.gov/medwatch/safety/2006/Aptivus_PI.pdf | |
|
|
|
